SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-003946
Filing Date
2019-03-26
Accepted
2019-03-26 16:46:34
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1133024
2 ex21-1.htm EX-21.1 5676
3 ex23-1.htm EX-23.1 5929
4 ex31-1.htm EX-31.1 19037
5 ex31-2.htm EX-31.2 19278
6 ex32-1.htm EX-32.1 9098
7 ex32-2.htm EX-32.2 8642
  Complete submission text file 0001493152-19-003946.txt   5244018

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE prph-20181231.xml EX-101.INS 845424
9 XBRL SCHEMA FILE prph-20181231.xsd EX-101.SCH 66981
10 XBRL CALCULATION FILE prph-20181231_cal.xml EX-101.CAL 81600
11 XBRL DEFINITION FILE prph-20181231_def.xml EX-101.DEF 193724
12 XBRL LABEL FILE prph-20181231_lab.xml EX-101.LAB 465117
13 XBRL PRESENTATION FILE prph-20181231_pre.xml EX-101.PRE 322330
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 19705764
SIC: 2834 Pharmaceutical Preparations